64
Participants
Start Date
July 31, 2009
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
BMS-866949
(Panel 1 - 0.5 mg) - Oral Solution, Oral, once, 14 days
BMS-866949
(Panel 2 - 2.5 mg) - Oral Solution, Oral, once, 14 days
BMS-866949
(Panel 3 - 10 mg) - Oral Solution, Oral, once, 14 days
BMS-866949
(Panel 4 - 25 mg) - Oral Solution, Oral, once, 14 days
BMS-866949
(Panel 5 - 50 mg) - Oral Solution, Oral, once, 14 days
BMS-866949
(Panel 6 - 100 mg) - Oral Solution, Oral, once, 14 days
BMS-866949
(Panel 7 - 150 mg) - Oral Solution, Oral, once, 14 days
Placebo
(Matching volume) - Oral Solution, Oral, once 14 days
Local Institution, Uppsala
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY